ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION
Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E498-E498 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | E498 |
---|---|
container_issue | 13 |
container_start_page | E498 |
container_title | Journal of the American College of Cardiology |
container_volume | 59 |
creator | Rasoul, Saman van't Hof, Arnoud Clare, Robert Atar, Dan James, Stefan Tanguay, Jean-Francois Betriu, Amadeo brogan, gerard Giugliano, Robert Newby, L. Kristin |
description | Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI). |
doi_str_mv | 10.1016/S0735-1097(12)60499-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1547354205</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0735109712604999</els_id><sourcerecordid>3380338311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1855-bd9cb7f4b95af8e5dfd3bcd988bef2bcc232f44748187b5e29c671a51729f4483</originalsourceid><addsrcrecordid>eNqFkdGO1CAUhonRxHH1EUxIvNHEKtAyhRtNbZldkhk6KYxmvCEtpUnXcWYtuyb7JL6uzMxGE2-8InC-_wPOAeAlRu8wwvP3GuUpTTDi-WtM3sxRxnnCH4EZppQlKeX5YzD7gzwFz0K4RgjNGeYz8KupN0YqAUXRLLdQrI1cyE-FkZV4C6VaFE1poJZf465QFYxwWa-EjiWoapVok2hxuRLKQLEUn2OuVrAoN0bAsm5qVTRbqLeqamIIrmM5khp-kebqgRcVNE29rlUUHqPVSmodJc_Bk6HdBf_iYb0Am4Uw5VWyrC9lWSwThxmlSddz1-VD1nHaDszTfujTzvWcsc4PpHOOpGTIsjxjmOUd9YS7eY5binPC4zlLL8Crs_dmOvy48-HWXh_upn280mKaxaZlBNFI0TPlpkMIkx_szTR-b6d7i5E9zsCeZmCPDbaY2NMMLI-5j-ecj1_4OfrJBjf6vfP9OHl3a_vD-F_Dh38MbjfuR9fuvvl7H_4-1gZi0VlydGByMvD0N4U5l04</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547354205</pqid></control><display><type>article</type><title>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</title><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Rasoul, Saman ; van't Hof, Arnoud ; Clare, Robert ; Atar, Dan ; James, Stefan ; Tanguay, Jean-Francois ; Betriu, Amadeo ; brogan, gerard ; Giugliano, Robert ; Newby, L. Kristin</creator><creatorcontrib>Rasoul, Saman ; van't Hof, Arnoud ; Clare, Robert ; Atar, Dan ; James, Stefan ; Tanguay, Jean-Francois ; Betriu, Amadeo ; brogan, gerard ; Giugliano, Robert ; Newby, L. Kristin</creatorcontrib><description>Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(12)60499-9</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Acute coronary syndromes ; Angina pectoris ; Cardiology ; Cardiovascular ; Heart attacks ; Internal Medicine</subject><ispartof>Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E498-E498</ispartof><rights>American College of Cardiology Foundation</rights><rights>2012 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Mar 27, 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0735109712604999$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids></links><search><creatorcontrib>Rasoul, Saman</creatorcontrib><creatorcontrib>van't Hof, Arnoud</creatorcontrib><creatorcontrib>Clare, Robert</creatorcontrib><creatorcontrib>Atar, Dan</creatorcontrib><creatorcontrib>James, Stefan</creatorcontrib><creatorcontrib>Tanguay, Jean-Francois</creatorcontrib><creatorcontrib>Betriu, Amadeo</creatorcontrib><creatorcontrib>brogan, gerard</creatorcontrib><creatorcontrib>Giugliano, Robert</creatorcontrib><creatorcontrib>Newby, L. Kristin</creatorcontrib><title>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</title><title>Journal of the American College of Cardiology</title><description>Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).</description><subject>Acute coronary syndromes</subject><subject>Angina pectoris</subject><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Heart attacks</subject><subject>Internal Medicine</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkdGO1CAUhonRxHH1EUxIvNHEKtAyhRtNbZldkhk6KYxmvCEtpUnXcWYtuyb7JL6uzMxGE2-8InC-_wPOAeAlRu8wwvP3GuUpTTDi-WtM3sxRxnnCH4EZppQlKeX5YzD7gzwFz0K4RgjNGeYz8KupN0YqAUXRLLdQrI1cyE-FkZV4C6VaFE1poJZf465QFYxwWa-EjiWoapVok2hxuRLKQLEUn2OuVrAoN0bAsm5qVTRbqLeqamIIrmM5khp-kebqgRcVNE29rlUUHqPVSmodJc_Bk6HdBf_iYb0Am4Uw5VWyrC9lWSwThxmlSddz1-VD1nHaDszTfujTzvWcsc4PpHOOpGTIsjxjmOUd9YS7eY5binPC4zlLL8Crs_dmOvy48-HWXh_upn280mKaxaZlBNFI0TPlpkMIkx_szTR-b6d7i5E9zsCeZmCPDbaY2NMMLI-5j-ecj1_4OfrJBjf6vfP9OHl3a_vD-F_Dh38MbjfuR9fuvvl7H_4-1gZi0VlydGByMvD0N4U5l04</recordid><startdate>20120327</startdate><enddate>20120327</enddate><creator>Rasoul, Saman</creator><creator>van't Hof, Arnoud</creator><creator>Clare, Robert</creator><creator>Atar, Dan</creator><creator>James, Stefan</creator><creator>Tanguay, Jean-Francois</creator><creator>Betriu, Amadeo</creator><creator>brogan, gerard</creator><creator>Giugliano, Robert</creator><creator>Newby, L. Kristin</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20120327</creationdate><title>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</title><author>Rasoul, Saman ; van't Hof, Arnoud ; Clare, Robert ; Atar, Dan ; James, Stefan ; Tanguay, Jean-Francois ; Betriu, Amadeo ; brogan, gerard ; Giugliano, Robert ; Newby, L. Kristin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1855-bd9cb7f4b95af8e5dfd3bcd988bef2bcc232f44748187b5e29c671a51729f4483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Acute coronary syndromes</topic><topic>Angina pectoris</topic><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Heart attacks</topic><topic>Internal Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasoul, Saman</creatorcontrib><creatorcontrib>van't Hof, Arnoud</creatorcontrib><creatorcontrib>Clare, Robert</creatorcontrib><creatorcontrib>Atar, Dan</creatorcontrib><creatorcontrib>James, Stefan</creatorcontrib><creatorcontrib>Tanguay, Jean-Francois</creatorcontrib><creatorcontrib>Betriu, Amadeo</creatorcontrib><creatorcontrib>brogan, gerard</creatorcontrib><creatorcontrib>Giugliano, Robert</creatorcontrib><creatorcontrib>Newby, L. Kristin</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasoul, Saman</au><au>van't Hof, Arnoud</au><au>Clare, Robert</au><au>Atar, Dan</au><au>James, Stefan</au><au>Tanguay, Jean-Francois</au><au>Betriu, Amadeo</au><au>brogan, gerard</au><au>Giugliano, Robert</au><au>Newby, L. Kristin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2012-03-27</date><risdate>2012</risdate><volume>59</volume><issue>13</issue><spage>E498</spage><epage>E498</epage><pages>E498-E498</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Background In the EARLY ACS trial, eptifibatide 12 hours or more before angiography was not superior to the provisional use of eptifibatide in patients with non-ST-segment elevation myocardial infarction (NSTE MI).</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(12)60499-9</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0735-1097 |
ispartof | Journal of the American College of Cardiology, 2012-03, Vol.59 (13), p.E498-E498 |
issn | 0735-1097 1558-3597 |
language | eng |
recordid | cdi_proquest_journals_1547354205 |
source | Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Acute coronary syndromes Angina pectoris Cardiology Cardiovascular Heart attacks Internal Medicine |
title | ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T22%3A22%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ROUTINE%20EARLY%20EPTIFIBATIDE,%20INFARCT%20SIZE,%20AND%20OUTCOMES%20IN%20NON-ST-SEGMENT%20ELEVATION%20ACUTE%20CORONARY%20SYNDROME%20PATIENTS%20WITH%20ELEVATED%20TROPONIN%20ON%20ADMISSION&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Rasoul,%20Saman&rft.date=2012-03-27&rft.volume=59&rft.issue=13&rft.spage=E498&rft.epage=E498&rft.pages=E498-E498&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(12)60499-9&rft_dat=%3Cproquest_cross%3E3380338311%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547354205&rft_id=info:pmid/&rft_els_id=1_s2_0_S0735109712604999&rfr_iscdi=true |